BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang X, He B, Chen E, Lu J, Wang J, Cao H, Li L. The aryl hydrocarbon receptor ligand ITE inhibits cell proliferation and migration and enhances sensitivity to drug-resistance in hepatocellular carcinoma. J Cell Physiol 2021;236:178-92. [PMID: 32510618 DOI: 10.1002/jcp.29832] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Wei K, Gao G, Chou Y, Lin C, Chen S, Chen Y, Choi HQ, Cheng C, Su JJ. Sorafenib is an antagonist of the aryl hydrocarbon receptor. Toxicology 2022. [DOI: 10.1016/j.tox.2022.153118] [Reference Citation Analysis]
2 Cannon AS, Nagarkatti PS, Nagarkatti M. Targeting AhR as a Novel Therapeutic Modality against Inflammatory Diseases. Int J Mol Sci 2021;23:288. [PMID: 35008717 DOI: 10.3390/ijms23010288] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
3 Yang Y, Chan WK. Glycogen Synthase Kinase 3 Beta Regulates the Human Aryl Hydrocarbon Receptor Cellular Content and Activity. Int J Mol Sci 2021;22:6097. [PMID: 34198826 DOI: 10.3390/ijms22116097] [Cited by in F6Publishing: 1] [Reference Citation Analysis]